CY1108152T1 - 17 αλφα-υδροξυ-14 βητα-στεροειδη με ορμονικη δραση - Google Patents
17 αλφα-υδροξυ-14 βητα-στεροειδη με ορμονικη δρασηInfo
- Publication number
- CY1108152T1 CY1108152T1 CY20081100653T CY081100653T CY1108152T1 CY 1108152 T1 CY1108152 T1 CY 1108152T1 CY 20081100653 T CY20081100653 T CY 20081100653T CY 081100653 T CY081100653 T CY 081100653T CY 1108152 T1 CY1108152 T1 CY 1108152T1
- Authority
- CY
- Cyprus
- Prior art keywords
- steroid
- beta
- alpha
- hydroxy
- hormone action
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 206010002261 Androgen deficiency Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- -1 steroid compounds Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 | ||
| EP02777036A EP1427748B1 (en) | 2001-09-12 | 2002-09-06 | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108152T1 true CY1108152T1 (el) | 2014-02-12 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100653T CY1108152T1 (el) | 2001-09-12 | 2008-06-19 | 17 αλφα-υδροξυ-14 βητα-στεροειδη με ορμονικη δραση |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (enExample) |
| EP (1) | EP1427748B1 (enExample) |
| JP (1) | JP4471653B2 (enExample) |
| KR (1) | KR100940054B1 (enExample) |
| CN (1) | CN1257913C (enExample) |
| AR (1) | AR036462A1 (enExample) |
| AT (1) | ATE395352T1 (enExample) |
| AU (1) | AU2002339536B2 (enExample) |
| BR (1) | BR0212409A (enExample) |
| CA (1) | CA2505575C (enExample) |
| CY (1) | CY1108152T1 (enExample) |
| DE (1) | DE60226623D1 (enExample) |
| DK (1) | DK1427748T3 (enExample) |
| EC (1) | ECSP045012A (enExample) |
| ES (1) | ES2305306T3 (enExample) |
| HR (1) | HRP20040193A2 (enExample) |
| HU (1) | HUP0402139A3 (enExample) |
| IL (2) | IL160451A0 (enExample) |
| IS (1) | IS2555B (enExample) |
| MX (1) | MXPA04002418A (enExample) |
| NO (1) | NO326624B1 (enExample) |
| NZ (1) | NZ531487A (enExample) |
| PL (1) | PL207493B1 (enExample) |
| PT (1) | PT1427748E (enExample) |
| RU (1) | RU2294332C2 (enExample) |
| TW (1) | TWI221154B (enExample) |
| WO (1) | WO2003022864A1 (enExample) |
| ZA (1) | ZA200401992B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| ATE228143T1 (de) | 1999-03-08 | 2002-12-15 | Akzo Nobel Nv | 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032805L (no) | Blandinger med ostrogen-syklodekstrinkomplekser | |
| FR17C0003I2 (fr) | Steroides comme agonistes de fxr | |
| CY1107793T1 (el) | Εκκριματαγωγa αυξητικhς ορμoνης | |
| PL369530A1 (en) | Chemical compounds | |
| TR200000595T2 (tr) | 2,3-Diaril-pirazolo[1,5-B]piridazinler türevleri, bunların hazırlanması ve bunların siklooksijenaz 2 (COX-2) inhibitörleri olarak kullanılması. | |
| SG148031A1 (en) | Use of cci-779 as an antineoplastic agent | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| BRPI0409632A (pt) | combinações antineoplásticas | |
| AU4584901A (en) | Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents | |
| MXPA02012944A (es) | Analogos de acido graso para el tratamiento de cancer. | |
| MY128709A (en) | Phosphonites | |
| PL352638A1 (en) | Novel derivatives and analogues of galanthamin | |
| CY1110377T1 (el) | Ανδρογονα 7-υποκατεστημενα 11-αλογονουχα στεροειδη | |
| UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| DE60127131D1 (de) | Tricyclische imidazopyridine | |
| CY1107485T1 (el) | 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα | |
| CY1106754T1 (el) | Σκευασματα τιμπολονης | |
| MXPA04002418A (es) | 17alfa-hidroxi-14-beta-esteroides con efecto hormonal. | |
| BR0313230A (pt) | Uso de carboxamidas para o tratamento de tinido | |
| CY1105798T1 (el) | Στepοειδη, η παρασκευη τους, φαρμακευτικες συνθεσεις απο αυτα και χρησεις των ενωσεων | |
| DK1392672T3 (da) | Chlormethylering af thiopen | |
| DE3661833D1 (de) | Steroidic aromatase inhibitors | |
| PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena | |
| CN309174494S (zh) | 市电互补一体化路灯 |